USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 176 filers reported holding USANA HEALTH SCIENCES INC in Q2 2019. The put-call ratio across all filers is 7.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6 | +100.0% | 124 | +93.8% | 0.00% | – |
Q4 2023 | $3 | -25.0% | 64 | 0.0% | 0.00% | – |
Q3 2023 | $4 | -20.0% | 64 | -11.1% | 0.00% | – |
Q2 2023 | $5 | 0.0% | 72 | 0.0% | 0.00% | – |
Q1 2023 | $5 | +66.7% | 72 | +20.0% | 0.00% | – |
Q4 2022 | $3 | -99.9% | 60 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 60 | +33.3% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 45 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | 0.0% | 45 | +2.3% | 0.00% | – |
Q4 2021 | $4,000 | -99.8% | 44 | -99.8% | 0.00% | -100.0% |
Q2 2020 | $1,799,000 | +350.9% | 24,500 | +255.1% | 0.01% | +200.0% |
Q1 2020 | $399,000 | -45.9% | 6,900 | -26.6% | 0.00% | 0.0% |
Q4 2019 | $738,000 | +14.8% | 9,400 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $643,000 | -62.9% | 9,400 | -56.9% | 0.00% | -66.7% |
Q2 2019 | $1,732,000 | -24.6% | 21,800 | -20.4% | 0.01% | -33.3% |
Q1 2019 | $2,298,000 | -10.9% | 27,400 | +25.1% | 0.01% | -18.2% |
Q4 2018 | $2,578,000 | +73.8% | 21,900 | +78.0% | 0.01% | +83.3% |
Q3 2018 | $1,483,000 | -2.6% | 12,300 | -6.8% | 0.01% | 0.0% |
Q2 2018 | $1,522,000 | +34.2% | 13,200 | 0.0% | 0.01% | +50.0% |
Q1 2018 | $1,134,000 | +18.7% | 13,200 | +2.3% | 0.00% | 0.0% |
Q4 2017 | $955,000 | +2.8% | 12,900 | -19.9% | 0.00% | 0.0% |
Q3 2017 | $929,000 | -5.9% | 16,100 | +4.5% | 0.00% | 0.0% |
Q2 2017 | $987,000 | +11.3% | 15,400 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $887,000 | -5.8% | 15,400 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $942,000 | -11.5% | 15,400 | +100.0% | 0.00% | -20.0% |
Q3 2016 | $1,065,000 | -2.3% | 7,700 | -9.8% | 0.01% | -16.7% |
Q4 2015 | $1,090,000 | -4.7% | 8,532 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $1,144,000 | +38.5% | 8,532 | -23.9% | 0.01% | +250.0% |
Q3 2014 | $826,000 | -5.7% | 11,210 | 0.0% | 0.00% | -60.0% |
Q2 2014 | $876,000 | +3.7% | 11,210 | 0.0% | 0.01% | -16.7% |
Q1 2014 | $845,000 | -0.2% | 11,210 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $847,000 | -12.9% | 11,210 | 0.0% | 0.01% | -25.0% |
Q3 2013 | $973,000 | – | 11,210 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |